Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy
about
Targeting innate immunity for neurodegenerative disorders of the central nervous systemAn overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levelsSecret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative researchObesity-Driven Gut Microbiota Inflammatory Pathways to Metabolic SyndromeA new perspective on the role of the CREB family of transcription factors in memory consolidation via adult hippocampal neurogenesisOxidized cholesterol as the driving force behind the development of Alzheimer's diseaseAtrial Fibrillation and Risk of Dementia/Cognitive DeclineEffects of Kaixinjieyu, a Chinese herbal medicine preparation, on neurovascular unit dysfunction in rats with vascular depressionSerum-borne bioactivity caused by pulmonary multiwalled carbon nanotubes induces neuroinflammation via blood-brain barrier impairmentAnti-Viral Properties of Amyloid-β Peptides.Influence of drug transporters and stereoselectivity on the brain penetration of pioglitazone as a potential medicine against Alzheimer's diseaseBody-Brain Connections: The Effects of Obesity and Behavioral Interventions on Neurocognitive Aging.The impact of microglial activation on blood-brain barrier in brain diseases.Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.Therapeutic Effects of PPAR α on Neuronal Death and Microvascular Impairment.Microbial Sources of Amyloid and Relevance to Amyloidogenesis and Alzheimer's Disease (AD).Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder?An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's diseaseDecreased expression of the APOA1-APOC3-APOA4 gene cluster is associated with risk of Alzheimer's disease.The neuropathology and cerebrovascular mechanisms of dementiaNonalcoholic fatty liver disease is associated with cognitive function in adults.Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's diseaseEndothelial Activation Is Associated With Cognitive Performance in Patients With HypertensionCognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive ImpairmentMitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer's DiseaseHyperammonemia induces glial activation, neuroinflammation and alters neurotransmitter receptors in hippocampus, impairing spatial learning: reversal by sulforaphaneCytokine signature associated with disease severity in chronic fatigue syndrome patients.Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model.The infectious etiology of Alzheimer's Disease.Atrial fibrillation, cognition and dementia: A review.Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration.Minimal hepatic encephalopathy is associated with expansion and activation of CD4+CD28-, Th22 and Tfh and B lymphocytesProtective effects of Dendrobium nobile Lindl. alkaloids on amyloid beta (25-35)-induced neuronal injury.High Serum Levels of Malondialdehyde and 8-OHdG are both Associated with Early Cognitive Impairment in Patients with Acute Ischaemic Stroke.Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson's and Alzheimer's disease.Microbial-generated amyloids and Alzheimer's disease (AD).Role of serum albumin as a nanoparticulate carrier for nose-to-brain delivery of R-flurbiprofen: implications for the treatment of Alzheimer's disease.Type 2 diabetes mellitus in the pathophysiology of Alzheimer's disease.Impact of diabetes mellitus and chronic liver disease on the incidence of dementia and all-cause mortality among patients with dementia.Periodontitis induced by bacterial infection exacerbates features of Alzheimer's disease in transgenic mice.
P2860
Q26744219-3FCBCB22-8302-4938-9A9C-F19879A88363Q26751302-2B934891-4265-46EA-A8E7-0655A45A7D5CQ26751362-852356E3-C1B4-4577-BEC4-8DA0D490B5B6Q26774779-009BA169-7DB1-4651-86C0-3ACFF152D8E4Q26785386-7DF56286-7CAB-4D55-9B0E-105144881460Q27023315-42809683-4300-4F97-BB88-CC2182EA0793Q28074311-3E32ABDC-DD97-40CD-B578-B38AE47A4C62Q28564382-09FC89E2-8023-4A37-8FCF-CAF93A0F51EFQ28950553-5593F6FD-DC0C-42B0-9A05-79357900BDE7Q30390299-BAE03BCB-CBAC-4E09-BFCF-D00478DAA712Q33562308-FA77E729-ED84-4A98-A67C-37C3414BF61FQ33619524-00143D38-9300-40B6-A319-23A1D0758AA7Q34442604-46BC2AFF-67B8-4FD5-B2CB-D47C726866EEQ34833657-BCA1AB65-938D-4A87-857D-85CDD6EC31ECQ35078274-EA0C550B-E3B0-42F2-B389-4307903C5EC1Q35597184-F98FAA56-4103-42ED-B5A1-797AB524120BQ35649716-A7A54D82-C823-4173-BBFA-41669B056322Q35907609-BD874FE6-4F58-47E2-827D-451113736153Q36137359-7685B964-A057-4DC5-9330-F6D46AF8D782Q36593201-1D1DF3D5-3518-4C9E-AA1F-4621202DB8ECQ36763378-7F36AB45-CEDF-480C-9984-BB76D4D29266Q36767796-124FDF3A-AEC4-45EB-9A7E-EEE4CFFF58D5Q36950132-57D4CF71-5AAF-4276-A9B6-507428C30FBAQ37054001-8E0007DE-B63F-4BA3-9669-4C5567E06E7DQ37613304-20878252-6D26-4A4E-8FA0-B2A8A8FBAD8AQ38484324-ADE1D56F-1B7B-490A-A231-B0CC45E5F53DQ38650803-7602DFD7-43CB-4BAE-8A08-13CD918EF336Q38797410-64061B3D-4558-45A6-B065-922773A94E7DQ39178926-C791B8DF-9471-40BD-8451-EA19B7BD29DFQ39343435-7344DE3A-5A2E-4DCA-9A52-176C0F245C82Q41097407-AF6FF9C2-07F8-427F-8075-B61F20800C06Q41159159-6DF6D73E-7CE7-42CC-BBBE-DC10A2D98515Q41429884-B47BC196-9A39-437A-B61F-F3E0D574C897Q41534498-11E16421-13FF-49EA-84D0-6943C21605BFQ41581073-DB915945-A064-40F7-9CD9-0808AA5C0DC6Q41885098-7EA1AA9B-3CB7-408A-961E-F9F607696FF4Q42516901-7BCF5100-CC4B-4941-9DDE-8C39B3461146Q47096119-97AA544E-3312-4445-B226-FCB022D082F3Q47097794-3672AB21-249A-4EDA-B76A-63D9D6ECE827Q47106052-796384FB-6C01-4A69-A408-E7B608D8F4AC
P2860
Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Systemic inflammation, blood-b ...... ce to pathogenesis and therapy
@en
type
label
Systemic inflammation, blood-b ...... ce to pathogenesis and therapy
@en
prefLabel
Systemic inflammation, blood-b ...... ce to pathogenesis and therapy
@en
P2093
P2860
P921
P356
P1476
Systemic inflammation, blood-b ...... ce to pathogenesis and therapy
@en
P2093
Naoyuki Sato
Ryuichi Morishita
Shuko Takeda
P2860
P356
10.3389/FNAGI.2014.00171
P577
2014-07-29T00:00:00Z